Pharmaceuticals

Rotavirus Vaccine Market Outlook 2026–2030 driven by global immunization programs

March 24, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Rotavirus Vaccine Market From 2026 To 2030?

The rotavirus vaccine market has experienced rapid growth in its size in recent years. Projections indicate it will expand from $10.14 billion in 2025 to $11.2 billion in 2026, at a compound annual growth rate (CAGR) of 10.4%. This growth in the historic period is attributable to several factors, including the increasing incidence of pediatric gastroenteritis, the expansion of national immunization schedules, the growth of public health vaccination campaigns, the availability of live attenuated vaccines, and rising awareness of rotavirus prevention.

The rotavirus vaccine market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $16.45 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.1%. This growth during the projection period stems from several factors, including the escalating demand for widespread pediatric vaccination, the broadening of combination vaccine innovation, increasing capital expenditure in vaccine production capabilities, a heightened emphasis on worldwide immunization coverage, and strengthened partnerships with public health organizations. Key trends anticipated within this forecast timeframe encompass the expanding scope of pediatric immunization schemes, a growing preference for oral vaccine types, an intensified focus on optimizing the vaccine cold chain, the widening of public health vaccination campaigns, and improved monitoring of rotavirus infections.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20617&type=smp

What Drivers Are Influencing The Rotavirus Vaccine Market?

The increase in birth rates is projected to boost the expansion of the rotavirus vaccine market in the future. Birth rates are defined as the yearly count of live births per 1,000 individuals within a population over a specified period. These rates are affected by increased economic stability and development, along with supportive government initiatives like parental leave, child benefits, and subsidies for childcare. Rotavirus vaccines play a role in lowering the occurrence of severe rotavirus gastroenteritis among infants, which in turn enhances children’s health and decreases the medical expenses linked to rotavirus infections. As an illustration, in January 2023, a report from the Centers for Disease Control and Prevention, a US-based national public health body, indicated that the United States experienced a 1% rise in recorded births, reaching 3,664,292, when compared to the prior year. Consequently, an uptick in birth rates will stimulate the growth of the rotavirus vaccine market.

Which Segments Are Included In The Analysis Of The Rotavirus Vaccine Market?

The rotavirus vaccine market covered in this report is segmented –

1) By Type: Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types

2) By Application: Adult, Pediatric

3) By End Users: Hospitals, Clinics, Academic Research

Which Trends Are Impacting The Growth Of The Rotavirus Vaccine Market?

Major companies involved in the rotavirus vaccine market are increasingly utilizing oral-dosing applicators to boost the efficiency of vaccine delivery and improve patient adherence. These oral-dosing applicators are medical instruments crafted for direct administration of liquid medications or vaccines into the mouth, guaranteeing precise dosing and simple application, particularly for infants and young children. As an illustration, in June 2025, Micron Biomedical, a U.S.-based biotechnology company, alongside Emory University, a U.S.-based private university, commenced a first-in-human clinical investigation of the inactivated rotavirus vaccine CC24, delivered via a dissolvable microarray patch. This patch features thermostability, thereby lessening reliance on cold chain infrastructure, facilitates self-administration, and generates no hazardous sharps waste. This advancement offers the prospect of expanded vaccine access in low-resource environments; nevertheless, regulatory approvals are still pending evaluation, and potential challenges in scaling up production might impede its widespread uptake in the rotavirus vaccine market.

Which Key Industry Participants Are Active In The Rotavirus Vaccine Market?

Major companies operating in the rotavirus vaccine market are Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd. , SK Chemicals Co Ltd, Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd

Read the full rotavirus vaccine market report here:

https://www.thebusinessresearchcompany.com/report/rotavirus-vaccine-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Rotavirus Vaccine Market?

North America was the largest region in the rotavirus vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotavirus vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Rotavirus Vaccine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20617&type=smp

Browse Through More Reports Similar to the Global Rotavirus Vaccine Market 2026, By The Business Research Company

Meningococcal Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report

Swine Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report

Typhoid Vi Polysaccharide Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/typhoid-vi-polysaccharide-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795